Cytokinetics Inc
NASDAQ:CYTK

Watchlist Manager
Cytokinetics Inc Logo
Cytokinetics Inc
NASDAQ:CYTK
Watchlist
Price: 55.96 USD -0.41% Market Closed
Market Cap: 6.6B USD
Have any thoughts about
Cytokinetics Inc?
Write Note

Wall Street
Price Targets

CYTK Price Targets Summary
Cytokinetics Inc

Wall Street analysts forecast CYTK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CYTK is 84.06 USD with a low forecast of 60.6 USD and a high forecast of 126 USD.

Lowest
Price Target
60.6 USD
8% Upside
Average
Price Target
84.06 USD
50% Upside
Highest
Price Target
126 USD
125% Upside

CYTK Last Price Targets
Cytokinetics Inc

The latest public price target was made on Oct 17, 2024 by Joseph Pantginis from H.C. Wainwright , who expects CYTK stock to rise by 114% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Joseph Pantginis
H.C. Wainwright
120 USD
Upside 114%
4 weeks ago
Oct 17, 2024
H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
StreetInsider
Paul Choi
Goldman Sachs
60 USD
Upside 7%
2 months ago
Sep 3, 2024
Goldman Sachs Reiterates Neutral Rating on Cytokinetics (CYTK)
StreetInsider
Yasmeen Rahimi
Piper Sandler
107 USD
Upside 91%
5 months ago
Jun 10, 2024
Piper Sandler Reiterates Overweight Rating on Cytokinetics (CYTK)
StreetInsider
Mayank Mamtani
B.Riley Financial
92 USD
Upside 64%
5 months ago
Jun 4, 2024
Cytokinetics (CYTK) PT Lowered to $92 at B.Riley
StreetInsider
Jason Butler
JMP Securities
78 USD
Upside 39%
5 months ago
May 28, 2024
Cytokinetics price target lowered to $78 from $106 at JMP Securities
TheFly
Carter Gould
Barclays
95 USD
Upside 70%
5 months ago
May 23, 2024
Cytokinetics price target lowered to $95 from $100 at Barclays
TheFly
Joseph Pantginis
H.C. Wainwright
90 USD
Upside 61%
5 months ago
May 23, 2024
Cytokinetics price target lowered to $90 from $94 at H.C. Wainwright
TheFly
Serge Belanger
Needham
72 USD
Upside 29%
5 months ago
May 23, 2024
Cytokinetics price target lowered to $72 from $108 at Needham
TheFly
Akash Tewari
Jefferies
85 USD
Upside 52%
5 months ago
May 23, 2024
Cytokinetics (CYTK) PT Lowered to $85 at Jefferies
StreetInsider
Jason Butler
JMP Securities
106 USD
Upside 89%
6 months ago
May 9, 2024
Cytokinetics price target lowered to $106 from $110 at JMP Securities
TheFly
Justin Kim
Oppenheimer
106 USD
Upside 89%
6 months ago
May 9, 2024
Cytokinetics price target lowered to $106 from $107 at Oppenheimer
TheFly
Salim Syed
Mizuho Securities
99 USD
Upside 77%
7 months ago
Apr 5, 2024
Mizuho on Cytokinetics (CYTK) Presentation: 'OREST oHCM 48wk Data @ ACC '24 ==> Incremental +ive'
StreetInsider
Show More Price Targets
Show Less Price Targets
Joseph Pantginis
H.C. Wainwright
Price Target 120 USD
Upside/Downside 114%
View Source
Paul Choi
Goldman Sachs
Price Target 60 USD
Upside/Downside 7%
View Source
Yasmeen Rahimi
Piper Sandler
Price Target 107 USD
Upside/Downside 91%
View Source
Mayank Mamtani
B.Riley Financial
Price Target 92 USD
Upside/Downside 64%
View Source
Jason Butler
JMP Securities
Price Target 78 USD
Upside/Downside 39%
View Source
Carter Gould
Barclays
Price Target 95 USD
Upside/Downside 70%
View Source
Joseph Pantginis
H.C. Wainwright
Price Target 90 USD
Upside/Downside 61%
View Source
Serge Belanger
Needham
Price Target 72 USD
Upside/Downside 29%
View Source
Akash Tewari
Jefferies
Price Target 85 USD
Upside/Downside 52%
View Source
Jason Butler
JMP Securities
Price Target 106 USD
Upside/Downside 89%
View Source
Justin Kim
Oppenheimer
Price Target 106 USD
Upside/Downside 89%
View Source
Salim Syed
Mizuho Securities
Price Target 99 USD
Upside/Downside 77%
View Source
Show More Price Targets
Show Less Price Targets
Cytokinetics Inc Competitors:
Price Targets
RXRX
Recursion Pharmaceuticals Inc
41% Upside
SNDX
Syndax Pharmaceuticals Inc
117% Upside
358570
GI Innovation Inc
116% Upside
IONS
Ionis Pharmaceuticals Inc
67% Upside
GLPG
Galapagos NV
52% Upside
ARTV
Artiva Biotherapeutics Inc
85% Upside
BCRX
BioCryst Pharmaceuticals Inc
93% Upside
STOK
Stoke Therapeutics Inc
72% Upside

Revenue
Forecast

Revenue Estimate
Cytokinetics Inc

For the last 8 years the compound annual growth rate for Cytokinetics Inc's revenue is -15%. The projected CAGR for the next 3 years is 260%.

-15%
Past Growth
260%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Cytokinetics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Cytokinetics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYTK's stock price target?
Price Target
84.06 USD

According to Wall Street analysts, the average 1-year price target for CYTK is 84.06 USD with a low forecast of 60.6 USD and a high forecast of 126 USD.

What is Cytokinetics Inc's Revenue forecast?
Projected CAGR
260%

For the last 8 years the compound annual growth rate for Cytokinetics Inc's revenue is -15%. The projected CAGR for the next 3 years is 260%.

Back to Top